NCM
TLSI icon

Nantahala Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Nantahala Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.28M Hold
2,070,827
– – 0.3% 77
2025
Q4 		$14.5M Buy
2,070,827
+30,582
+1% +$171K 0.48% 51
2025
Q3 		$9.49M Buy
2,040,245
+40,245
+2% +$188K 0.33% 72
2025
Q2 		$10.9M Buy
+2,000,000
New +$10.7M 0.43% 51

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Nantahala Capital Management's TLSI Position: Q1 2026 in Review

Nantahala Capital Management held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 2,070,827 shares worth $8.28M. The position accounts for 0.3% of the portfolio, ranked #77.

Nantahala Capital Management first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.5M in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Nantahala Capital Management held 2,070,827 shares of TriSalus Life Sciences worth $8.28M as of Q1 2026.
  • Nantahala Capital Management left its TriSalus Life Sciences share count unchanged in Q1 2026.
  • TriSalus Life Sciences made up 0.3% of Nantahala Capital Management's portfolio in Q1 2026, its #77 holding.
  • Nantahala Capital Management first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Nantahala Capital Management's TriSalus Life Sciences position peaked at $14.5M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.